Workflow
Tobacco
icon
Search documents
Altria: 7.5% Yield Is Underwritten By Cigarettes, Not Vapes And Oral Pouches (NYSE:MO)
Seeking Alpha· 2026-01-11 10:05
Core Viewpoint - The article emphasizes the identification of high-quality, shareholder-oriented companies that are undervalued due to short-term market factors or irrational investor behavior [1] Group 1: Investment Focus - The current focus is on legacy businesses in sectors such as remittances, ATMs, and tobacco, which are perceived to be in secular decline [1] - There is a particular interest in cash-generative, high-yield stocks that often exhibit under-appreciated revenue and earnings growth [1] Group 2: Geographic Scope - While the primary emphasis is on U.S. stocks, the analysis also includes attractive investment opportunities in the UK and globally [1]
Altria: High Yield Is Underwritten By Cigarettes, Not Vapes And Oral Pouches
Seeking Alpha· 2026-01-11 10:05
Core Viewpoint - The article emphasizes the identification of high-quality, shareholder-oriented companies that are undervalued by the market due to short-term factors or irrational investor behavior [1] Group 1: Investment Focus - The current focus is on legacy businesses in sectors such as remittances, ATMs, and tobacco, which are perceived to be in secular decline [1] - There is a particular interest in cash-generative, high-yield stocks that often exhibit under-appreciated revenue and earnings growth [1] Group 2: Geographic Scope - While the primary emphasis is on U.S. stocks, the analysis also includes attractive investment opportunities in the UK and globally [1]
British American Tobacco: FY26 Outlook Points To 10%+ Total Shareholder Yield
Seeking Alpha· 2026-01-09 22:02
Group 1 - The article discusses the expertise of Sensor Unlimited, who has a PhD in financial economics and has been covering the mortgage market, commercial market, and banking industry for a decade [2] - Sensor Unlimited focuses on asset allocation and ETFs related to the overall market, bonds, banking and financial sectors, and housing markets [2] - The investing group Envision Early Retirement, led by Sensor Unlimited, offers solutions for generating high income and growth with isolated risks through dynamic asset allocation [2] Group 2 - Envision Early Retirement features two model portfolios: one for short-term survival/withdrawal and another for aggressive long-term growth [2] - The group provides direct access via chat for discussing ideas, monthly updates on holdings, tax discussions, and ticker critiques by request [2]
Fed Governor Wants Huge Rate Cuts This Year: 5 High-Yield Dividend Stocks to Buy Today
247Wallst· 2026-01-08 13:41
分组1: Federal Reserve and Economic Policy - Federal Reserve Governor Stephen Miran advocates for over 100 basis points of rate cuts in 2026 to stimulate economic growth, arguing that current monetary policy is restrictive [1][2] - Miran's views contrast with most Fed officials who are cautious about future rate cuts, reflecting concerns about the labor market and economic expansion [2] - If the economy declines significantly in early 2026, it is likely that the Federal Reserve would respond with rapid rate cuts, similar to past economic crises [3] 分组2: High-Yield Dividend Stocks - A screening of high-yield dividend stocks identified five companies yielding at least 5% and rated as Buy by top Wall Street firms, suitable for growth and income investors [4] - High-yield dividend stocks provide a reliable source of passive income, appealing to investors seeking to diversify income streams [5] 分组3: Altria Group Inc. - Altria Group Inc. offers a 7.06% dividend yield and is a major producer of tobacco products, primarily selling cigarettes under the Marlboro brand [6] - The company sold 35 million shares of Anheuser-Busch, representing 18% of its holdings, and announced a $2.4 billion stock repurchase plan [7] 分组4: Energy Transfer L.P. - Energy Transfer L.P. is a leading midstream energy company with a 7.97% distribution yield, owning over 114,000 miles of pipelines across the U.S. [10][11] - The company has a strong market position following its acquisition of Enable Partners and has an Overweight rating from J.P. Morgan with a $21 price target [12] 分组5: Pfizer Inc. - Pfizer Inc. pays a 6.80% dividend and has seen a decline in stock performance post-COVID-19 vaccine success, with anticipated revenues of around $62 billion for 2025 [14][15] - The company has a history of increasing dividends annually for the past 14 years, indicating financial stability [14] 分组6: United Parcel Service Inc. (UPS) - UPS plans to cut its shipping volume for Amazon by over 50% by the second half of 2026, impacting its dividend yield, which is currently at 6.57% [19] - The company aims to focus on more profitable business segments amid expectations of slower economic growth [19] 分组7: Verizon Communications Inc. - Verizon offers a 6.72% dividend and trades at 9.13 times its estimated 2026 earnings, with a stable revenue stream from telecom services [22][23] - The company has a strong interest coverage ratio, providing a cushion for dividend payments, and operates in both consumer and business segments [23][27]
Could Altria Help You Become a Millionaire?
Yahoo Finance· 2026-01-07 00:20
Core Insights - Altria is a leading consumer staples company known for its Marlboro cigarette brand, which holds a 40% overall market share and nearly 60% of the premium market share in the U.S. [6] - The company offers a high dividend yield of 7.4%, appealing to dividend investors [10] - Despite its strong brand presence, Altria's core business is in decline, with significant reductions in cigarette sales volume over recent years [11] Business Performance - Smokable tobacco products account for nearly 90% of Altria's revenues, with cigarettes making up just over 97% of its smokable tobacco product volumes [5] - Altria's cigarette sales volume decreased by 8.2% in Q3 2025 compared to Q3 2024, and a total decline of 10.6% was observed in the first nine months of 2025 [8] - This decline continues a long-term trend, with cigarette volumes down 10.2% in 2024, 9.9% in 2023, and 9.7% in 2022 [8] Investment Considerations - Altria's reliance on a single product, primarily Marlboro, which accounts for approximately 88% of its cigarette sales, raises concerns about its long-term sustainability [6] - The company generates substantial cash flow, allowing it to maintain and even increase its dividend despite the declining business fundamentals [11] - Investors should be cautious, as the ongoing decline in core business may not align with the attractive dividend yield [11]
Is Altria's 7.4%-Yielding Dividend Safe?
Yahoo Finance· 2026-01-06 19:50
Core Viewpoint - Dividend stocks, particularly those with high yields, are attractive to investors as interest rates decline, but sustainability of these dividends is a significant concern [1][2]. Company Analysis - Altria Group (NYSE: MO) offers a high dividend yield of 7.4%, significantly above the S&P 500 average of 1.1%, raising questions about the safety of this yield [3]. - Altria has a strong history of dividend payments, having increased its dividend 60 times over 56 years, qualifying it as a Dividend King [5]. - Despite its impressive dividend history, past performance does not guarantee future dividend growth, necessitating a broader evaluation of the company's prospects [6]. Growth Concerns - Altria faces challenges with growth, as stagnant or declining earnings can hinder its ability to maintain and grow dividends while investing in operations [7]. - The company's attempts to diversify into oral tobacco products have not yielded significant results, and declining smoking rates raise concerns about its long-term viability [8]. - While Altria has maintained its dividend for decades, recent struggles in revenue growth highlight the importance of considering future prospects when investing in dividend stocks [9].
22nd Century Files VLN® MRTP Renewal – Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less
Globenewswire· 2026-01-06 11:10
Core Viewpoint - 22nd Century Group, Inc. is advancing the fight against smoking-related health harms through its VLN reduced nicotine content products, which have been authorized by the FDA as a Modified Risk Tobacco Product [1][4]. Group 1: Product and Market Impact - The VLN reduced nicotine content cigarettes have been shown to lower daily nicotine consumption by 40% over 12 weeks in a study with over 400 participants, indicating their potential to reduce smoking rates and increase quit attempts [2]. - Approximately 28.8 million smokers in the U.S. contribute to over $600 billion in annual healthcare costs related to tobacco harm, highlighting the significant market opportunity for VLN products [2]. - VLN cigarettes contain 95% less nicotine than conventional cigarettes, providing a non-addictive alternative for smokers [3][10]. Group 2: Regulatory and Strategic Developments - The FDA originally authorized VLN combustible cigarettes in December 2021 for a five-year period, with a renewal application filed for December 2026 [3]. - The company is expanding its range of VLN branded products and tobacco plant varieties to offer smokers more low-nicotine alternatives, aligning with the FDA's proposed guidelines for low nicotine [5]. - The renewal process is part of the company's ongoing research and development efforts to advance reduced nicotine content in tobacco and introduce additional VLN products [5]. Group 3: Company Vision and Leadership - The CEO of 22nd Century Group emphasized that the FDA's MRTP authorization for VLN cigarettes represents a forward-thinking approach to reducing smoking-related health harms, focusing on behavioral and social aspects of nicotine addiction [4]. - The company aims to empower smokers to take control of their nicotine consumption through its innovative VLN products, positioning itself as a leader in the tobacco harm reduction movement [8][9].
Is Altria's Smoke-Free Push Enough to Stabilize Growth Over Time?
ZACKS· 2026-01-05 14:31
Core Insights - Altria Group, Inc. is adjusting its growth strategy in response to declining cigarette demand, focusing on a diversified smoke-free portfolio to stabilize growth over time [1][4] Group 1: Altria's Strategy and Performance - Domestic cigarette shipment volumes for Altria fell by 8.2% in Q3 2025, influenced by the rise of flavored disposable e-vapor products and tighter consumer spending [1][8] - Altria is emphasizing a diversified smoke-free portfolio that includes oral nicotine, e-vapor, and heated tobacco to adapt to changing consumer preferences [1][4] - The oral nicotine segment is showing the strongest progress, with Altria's nicotine pouch brand, on!, holding an 8.7% retail share of the total oral tobacco category in the first nine months of 2025 [2] - Altria launched on! PLUS, a premium nicotine pouch aimed at traditional smokeless tobacco users and competing pouch consumers [2][8] - The company is facing challenges in the e-vapor market as it integrates NJOY, while also advancing its heated tobacco efforts through the Horizon joint venture [3][4] Group 2: Competitive Landscape - Philip Morris International Inc. is also shifting towards smoke-free products, with these products accounting for approximately 41% of its net revenues in Q3 2025, and shipment volumes increasing by 16.6% year over year [5] - Turning Point Brands, Inc. reported a significant increase in Modern Oral sales, which surged by 627.6% year over year to $36.7 million, representing about 30.8% of total net sales [6] Group 3: Financial Metrics and Estimates - Altria's shares have gained 0.6% over the past month, compared to the industry's growth of 5.2% [7] - The forward price-to-earnings ratio for Altria is 10.3X, lower than the industry's average of 14.35X [9] - The Zacks Consensus Estimate for Altria's earnings implies year-over-year growth of 6.3% for 2025 and 2.3% for 2026 [10]
Altria: A Turnaround Stock For 2026 (Rating Upgrade)
Seeking Alpha· 2026-01-02 20:29
Core Viewpoint - Altria (MO) is positioned as a potential turnaround candidate in 2026 due to recent announcements and successful regulatory approvals for new nicotine pouches [1] Group 1: Company Developments - Altria has announced a leadership transition, indicating a shift in management strategy [1] - The company has successfully secured regulatory approvals for new nicotine pouches, which may enhance its product offerings and market position [1] Group 2: Market Potential - The introduction of new nicotine pouches could significantly impact Altria's market presence and revenue streams, suggesting a positive outlook for the company's future [1]
Here's What to Expect From Altria Group’s Next Earnings Report
Yahoo Finance· 2026-01-02 10:15
Company Overview - Altria Group, Inc. is valued at $96.8 billion and is a leading tobacco company based in Richmond, Virginia, known for brands like Marlboro and Copenhagen [1] Financial Performance - Analysts expect Altria to report an adjusted EPS of $1.30 for the upcoming fourth quarter, a slight increase from $1.29 in the same quarter last year [2] - For fiscal 2025, Altria's adjusted EPS is projected to be $5.44, reflecting a 6.3% increase from $5.12 in fiscal 2024, with further growth expected to $5.56 in FY2026 [3] Stock Performance - Over the past 52 weeks, Altria's shares have increased by 10.8%, which is lower than the S&P 500 Index's return of 16.4% but better than the Consumer Staples Select Sector SPDR Fund's slight decline [4] Dividend Policy - Altria announced a quarterly dividend of $1.06 per share, scheduled for payment on January 9, 2026, demonstrating the company's commitment to returning capital to shareholders [5] Analyst Ratings - The consensus rating for Altria is neutral with a "Hold" recommendation; among 14 analysts, 4 suggest "Strong Buy," 8 recommend "Hold," 1 advises "Moderate Sell," and 1 gives a "Strong Sell" rating, with a mean price target of $61.45 indicating a potential upside of 6.6% [6]